image skincare vol.u.lift glp-1 4d skin rebound complex Now available at Elixir Treatments! VOL.U.LIFT™ featuring This first-to-market formula was developed by plastic surgeon, Dr. Marc Ronert, to address the four visible side effects of GLP-1 or thinning skin texture. VOL.U.LIFT GLP-1 4D Skin Rebound

As of December 2024, the FDA approved tirzepatide for treatment of moderate-to-severe obstructive sleep apnea (OSA) in patients with obesity based on the results of two trials

This allows treatment decisions to be based on your progress over time rather than a single appointment

The announcement adds to a string of setbacks in the company's bid to win a slice of the booming market for GLP-1s, which mimic certain gut hormones to tamp down appetite and regulate blood sugar

Weight loss may slow down or plateau, and progress should also be measured by improvements in energy, blood sugar, and overall health

On August 13th I was 200.6lbs, and on September 3rd the day before flying to visit my parents I weighed 213.4lbs, a shocking weight gain